Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
prothrombin complex
- Development stage
- Phase 4
- Lead developer
- CSL Behring
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
Prothrombinex-VF is a human plasma-derived three-factor prothrombin complex concentrate (PCC) manufactured by CSL Behring. It contains concentrated vitamin K-dependent coagulation factors II (prothrombin), IX, and X, along with antithrombin III and heparin sodium, but notably contains minimal amounts of factor VII. It is primarily indicated for the rapid reversal of warfarin-induced anticoagulation (warfarin-associated coagulopathy) in patients experiencing major bleeding or requiring urgent surgery. Additionally, it is used for the treatment and perioperative prophylaxis of bleeding in patients with congenital deficiencies of factors II, IX, or X when specific single-factor concentrates are unavailable. By replenishing these essential components of the coagulation cascade, Prothrombinex-VF restores hemostatic potential and restores the patient's ability to form stable blood clots.
- Brand names
- Prothrombinex-VF
- Other names
- 3-factor prothrombin complex concentrate3-factor PCC
02
Targets
ATIII (Antithrombin III)F2 (Thrombin)F9 (Coagulation Factor IX)F5 (Coagulation Factor V)F7 (Coagulation Factor VII)F10 (Factor Xa)
Beyond the preview
Go deeper on prothrombin complex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on prothrombin complex.